Cellares Interview Guide

Cellares is a pioneering Integrated Development and Manufacturing Organization (IDMO) that is at the forefront of revolutionizing the mass manufacturing of cell therapies, recognized as the living drugs of the 21st century. By leveraging an Industry 4.0 approach, Cellares develops and operates cutting-edge technologies designed to accelerate access to life-saving treatments. Central to its innovation is the Cell Shuttle platform, which enables a fully automated, high-throughput manufacturing process deployed in Smart Factories worldwide, effectively addressing the growing demand for cell therapies. Headquartered in South San Francisco, California, and with a commercial-scale facility in Bridgewater, New Jersey, Cellares has successfully raised over $355 million in funding from distinguished investors, establishing itself as a leader in enhancing drug development and manufacturing efficiency.